These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19085915)

  • 1. Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion.
    Kawasaki T; Koga H; Serikawa T; Orita Y; Ikeda S; Mito T; Gotou Y; Shintani Y; Tanaka A; Tanaka H; Fukuyama T; Koga N
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):205-11. PubMed ID: 19085915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflation time and drug-eluting stent: the longer, the better..
    Bertrand OF
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
    [No Abstract]   [Full Text] [Related]  

  • 3. Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents.
    Chen SL; Zhang JJ; Ye F; Chen YD; Zhu ZS; Lin S; Tian NL; Liu ZZ; Fang WY; Sun XW; Hu DY; Kwan TW
    Chin Med J (Engl); 2008 Mar; 121(6):528-33. PubMed ID: 18364140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
    Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
    Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures.
    Javaid A; Chu WW; Cheneau E; Clavijo LC; Satler LF; Kent KM; Weissman NJ; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2006; 7(4):208-11. PubMed ID: 17174865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
    Johnson TW; Kay IP; Ormiston JA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
    Ormiston JA; Abizaid A; Spertus J; Fajadet J; Mauri L; Schofer J; Verheye S; Dens J; Thuesen L; Dubois C; Hoffmann R; Wijns W; Fitzgerald PJ; Popma JJ; Macours N; Cebrian A; Stoll HP; Rogers C; Spaulding C;
    Circ Cardiovasc Interv; 2010 Dec; 3(6):556-64. PubMed ID: 21062998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation.
    Muraoka Y; Sonoda S; Tsuda Y; Tanaka S; Okazaki M; Otsuji Y
    Heart Vessels; 2011 Nov; 26(6):565-71. PubMed ID: 21181171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound assessment of drug-eluting stent expansion.
    de Ribamar Costa J; Mintz GS; Carlier SG; Fujii K; Sano K; Kimura M; Tanaka K; Costa RA; Lui J; Na Y; Castellanos C; Biro S; Moussa I; Stone GW; Moses JW; Leon MB
    Am Heart J; 2007 Feb; 153(2):297-303. PubMed ID: 17239693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better stent expansion by two-time inflation of stent balloon and its responsible mechanism.
    Iwamoto Y; Okamoto M; Hashimoto M; Fukuda Y; Iwamoto A; Iwasaki T; Kinoshita H; Kihara Y
    J Cardiol; 2012 Mar; 59(2):160-6. PubMed ID: 22266460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
    Bailey SR
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
    [No Abstract]   [Full Text] [Related]  

  • 20. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.